Skip to main content
Log in

Botulinum toxin for gastrointestinal disorders: Therapy and mechanisms

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Botulinum toxin has gained widespread acceptance as a treatment option for various spastic gastrointestinal disorders such as achalasia, gastroparesis, sphincter of Oddi dysfunction, chronic anal fissures, and pelvic floor dyssnergia, despite the lack of strong evidence supporting its use in many of these disorders. This review summarizes the trials investigating the use of BoNT since it was first utilized as a treatment in achalasia. BoNT has proven to be safe, but long-term efficacy in many disorders has not been observed, primarily due to is relatively short duration of action. BoNT may be most useful in confirming a diagnosis which can lead to a more definitive treatment modality. Furthermore, its safety profile allows it to be a useful alternative in patients who are at high risk for invasive procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abbott RD, H Petrovitch, LR White, KH Masaki, CM Tanner, JD Curb, A Grandinetti, PL Blanchette, JS Popper and GW Ross (2001) Frequency of bowel movements and the future risk of Parkinson’s disease.Neurology 57(3), 456–462.

    Article  CAS  PubMed  Google Scholar 

  • Albanese A, G Maria, AR Bentivoglio, G Brisinda, E Cassetta and P Tonali (1997) Severe constipation in Parkinson’s disease relieved by botulinum toxin.Mov. Disord. 12(5), 764–766.

    Article  CAS  PubMed  Google Scholar 

  • Albanese A, G Brisinda, AR Bentivoglio and G Maria (2003) Treatment of outlet obstruction constipation in Parkinson’s disease with botulinum neurotoxin A.Am. J. Gastroenterol. 98(6), 1439–1440.

    Article  CAS  PubMed  Google Scholar 

  • Albani G, ML Petroni, A Mauro, A Liuzzi, G Lezzi, B Verti, P Marzullo and L Cattani (2005) Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study.J. Gastroenterol. 40(8), 833–835.

    Article  PubMed  Google Scholar 

  • Alberty J, M Oelerich, K Ludwig, S Hartmann and W Stoll (2000) Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction.Laryngoscope 110(7), 1151–1156.

    Article  CAS  PubMed  Google Scholar 

  • Annese V, M Basciani, F Perri, G Lombardi, V Frusciante, P Simone, A Andriulli and G Vantrappen (1996) Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia.Gastroenterology 111(6), 1418–1424.

    Article  CAS  PubMed  Google Scholar 

  • Annese V, G. Bassotti, G Coccia, V D’Onofrio, G Gatto, A Repici and A Andriulli (1999) Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group.Aliment. Pharmacol. Ther. 13(10), 1347–1350.

    Article  CAS  PubMed  Google Scholar 

  • Annese V, G Bassotti, G Coccia, M Dinelli, V D’Onofrio, G Gatto, G Leandro, A Repici, PA Testoni and A Andriulli (2000) A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.Gut 46(5), 597–600.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Argov S and O Levandovsky (2000) Open lateral sphincterotomy is still the best treatment for chronic anal fissure.Am. J. Surg. 179(3), 201–202.

    Article  CAS  PubMed  Google Scholar 

  • Arroyo A, F Perez, P Serrano, F Candela, J Lacueva and R Calpena (2005a) Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study.Am. J. Surg. 189(4), 429–434.

    Article  CAS  PubMed  Google Scholar 

  • Arroyo A, F Perez-Vicente, E Miranda, P Serrano, M Perez-Vazquez and R Calpena (2005b) [Manometric factors associated with recurrence in botulinum toxin treatment for chronic anal fissure.].Gastroenterol. Hepatol. 28(6), 311–314.

    Article  CAS  PubMed  Google Scholar 

  • Bachmann G, M Streppel, B Krug and E Neuen-Jacob (2001) Cricopharyngeal muscle hypertrophy associated with florid myositis.Dysphagia 16(4), 244–248.

    Article  CAS  PubMed  Google Scholar 

  • Bansal R, TT Nostrant, JM Scheiman, S Koshy, JL Barnett, GH Elta and WD Chey (2003) Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary acha-lasia.J. Clin. Gastroenterol. 36(3), 209–214.

    Article  CAS  PubMed  Google Scholar 

  • Barnes PR, PR Hawley, DM Preston and JE Lennard-Jones (1985) Experience of posterior division of the puborectalis muscle in the management of chronic constipation.Br. J. Surg. 72(6), 475–477.

    Article  CAS  PubMed  Google Scholar 

  • Bassotti G, F Chistolini, F Sietchiping-Nzepa, G de Roberto, A Morelli and G Chiarioni (2004) Biofeedback for pelvic floor dysfunction in constipation.Bmj 328(7436), 393–396.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bonavina L, R Incarbone, L Antoniazzi, M Reitano and A Peracchia (1999) Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia.Ital. J. Gastroenterol. Hepatol. 31(9), 827–830.

    CAS  PubMed  Google Scholar 

  • Bonavina L, R Incarbone, M Reitano, L Antoniazzi and A Peracchia (2000) Does previous endoscopic treatment affect the outcome of laparoscopic Heller myotomy?Ann. Chir. 125(1), 45–49.

    Article  CAS  PubMed  Google Scholar 

  • Brant CQ, ES Siqueira and AP Ferrari Jr (1999) Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection.Dis. Esophagus 12(1), 68–73.

    Article  CAS  PubMed  Google Scholar 

  • Brisinda G and G Maria (2000) Oral nifedipine reduces resting anal pressure and heals chronic anal fissure.Br. J. Surg. 87(2), 251.

    Article  CAS  PubMed  Google Scholar 

  • Brisinda G, G Maria, AR Bentivoglio, E Cassetta, D Gui and A Albanese (1999) A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure.N. Engl. J. Med. 341(2), 65–69.

    Article  CAS  PubMed  Google Scholar 

  • Brisinda G, G Maria, G Sganga, AR Bentivoglio, A Albanese and M Castagneto (2002) Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures.Surgery 131(2), 179–184.

    Article  PubMed  Google Scholar 

  • Brisinda G, A Albanese, F Cadeddu, AR Bentivoglio, A Mabisombi, G Marniga and G Maria (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomized “Botoxvs. Dysport” controlled trial.Aliment. Pharmacol. Ther. 19(6), 695–701.

    Article  CAS  PubMed  Google Scholar 

  • Bromer MQ, F Friedenberg, LS Miller, RS Fisher, K Swartz and HP Parkman (2005) Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.Gastrointest. Endosc. 61(7), 833–839.

    Article  PubMed  Google Scholar 

  • Brown AC, JM Sumfestand JV Rozwadowski (1989) Histopathology of the internal anal sphincter in chronic anal fissure.Dis. Colon Rectum 32(8), 680–683.

    Article  CAS  PubMed  Google Scholar 

  • Chiu MJ, YC Chang and TY Hsiao (2004) Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review.Dysphagia 19(1), 52–57.

    Article  PubMed  Google Scholar 

  • Cook TA, MM Humphreys and NJ McMortensen (1999) Oral nifedipine reduces resting anal pressure and heals chronic anal fissure.Br. J. Surg. 86(10), 1269–1273.

    Article  CAS  PubMed  Google Scholar 

  • Csendes A, G Smok, I Braghetto, C Ramirez, N Velasco and A Henriquez (1985) Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus.Dig. Dis. Sci. 30(10), 941–945.

    Article  CAS  PubMed  Google Scholar 

  • Ezzeddine D, R Jit, N Katz, N Gopalswamy and MS Bhutani (2002) Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.Gastrointest. Endosc. 55(7), 920–923.

    Article  PubMed  Google Scholar 

  • Garcia-Compean D, E Mendoza-Fuerte, JA Martinez, I Villarreal and H Maldonado (2005) Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study.Gastroenterol. Clin. Biol. 29(8-9), 789–791.

    Article  CAS  PubMed  Google Scholar 

  • Geenen JE, WJ Hogan, WJ Dodds, J Toouli and RP Venu (1989) The efficacy of endoscopic sphincterotomy after cholecystec-tomy in patients with sphincter-of-Oddi dysfunction.N. Engl. J. Med. 320(2), 82–87.

    Article  CAS  PubMed  Google Scholar 

  • Giral A, K Memisoglu, Y Gultekin, N Imeryuz, C Kalayci, NB Ulusoy and N Tozun (2004) Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial.BMC Gastroenterol. 4,7.

    Article  PubMed Central  PubMed  Google Scholar 

  • Gui D, A De Gaetano, PL Spada, A Viggiano, E Cassetta and A Albanese (2000) Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats.Aliment. Pharmacol. Ther. 14(6), 829–834.

    Article  CAS  PubMed  Google Scholar 

  • Gupta P and S S Rao (2002) Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report.Gastrointest. Endosc. 56(5), 770–772.

    Article  PubMed  Google Scholar 

  • Haapaniemi JJ, EA Laurikainen, J Pulkkinen and RJ Marttila (2001) Botulinum toxin in the treatment of cricopharyngeal dysphagia.Dysphagia 16(3), 171–175.

    Article  CAS  PubMed  Google Scholar 

  • Hallan RI, NS Williams, J Melling, DJ Waldron, NR Womack and JF Morrison (1988) Treatment of anismus in intractable constipation with botulinum A toxin.Lancet 2(8613), 714–717.

    Article  CAS  PubMed  Google Scholar 

  • Halum SL, SG Butler, JA Koufman and GN Postma (2005) Treatment of globus by upper esophageal sphincter injection with botulinum A toxin.Ear Nose Throat J. 84(2), 74.

    PubMed  Google Scholar 

  • Hananel N and PH Gordon (1997) Lateral internal sphincterotomy for fissure-in-ano--revisited.Dis. Colon Rectum 40(5), 597–602.

    Article  CAS  PubMed  Google Scholar 

  • Hansen MB (2003) The enteric nervous system I: organisation and classification.Pharmacol. Toxicol. 92(3), 105–113.

    Article  CAS  PubMed  Google Scholar 

  • Henry MA and RG Prado (1998) [Use of botulin toxin in the treatment of diffuse esophageal spasm. A case report].Arq. Gastroenterol. 35(4), 274–277.

    CAS  PubMed  Google Scholar 

  • Horgan S, K Hudda, T Eubanks, J McAllister and CA Pellegrini (1999) Does botulinum toxin injection make esophagomyotomy a more difficult operation?Surg. Endosc. 13(6), 576–579.

    Article  CAS  PubMed  Google Scholar 

  • Iswariah H, J Stephens, N Rieger, D Rodda and P Hewett (2005) Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano.ANZ J. Surg. 75(7), 553–555.

    Article  PubMed  Google Scholar 

  • James AN, JP Ryan, and HP Parkman (2003) Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle.Am. J. Physiol. Gastrointest. Liver Physiol. 285(2), G291-G297.

    Article  CAS  PubMed  Google Scholar 

  • Joo JS, F Agachan, B Wolff, JJ Nogueras and SD Wexner (1996) Initial North American experience with botulinum toxin type A for treatment of anismus.Dis. Colon Rectum 39(10), 1107–1111.

    Article  CAS  PubMed  Google Scholar 

  • Kelly JH (2000) Management of upper esophageal sphincter disorders: indications and complications of myotomy.Am. J. Med. 108 Suppl. 4a, 43S-46S.

    Article  PubMed  Google Scholar 

  • Kennedy ML, S Sowter, H Nguyen and DZ Lubowski (1999) Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and long-term follow-up.Dis. Colon Rectum 42(8), 1000–1006.

    Article  CAS  PubMed  Google Scholar 

  • Lacy BE, EN Zayat, MD Crowell and MM Schuster (2002) Botulinum toxin for the treatment of gastroparesis: a preliminary report.Am. J. Gastroenterol. 97(6), 1548–1552.

    Article  CAS  PubMed  Google Scholar 

  • Lacy BE, MD Crowell, A Schettler-Duncan, C Mathis and PJ Pasricha (2004) The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.Diabetes Care 27(10), 2341–2347.

    Article  CAS  PubMed  Google Scholar 

  • Lewis TH, ML Corman, ED Prager and WG Robertson (1988) Long-term results of open and closed sphincterotomy for anal fissure.Dis. Colon Rectum 31(5), 368–371.

    Article  CAS  PubMed  Google Scholar 

  • Liu LW, M Tarnopolsky and D Armstrong (2004) Injection of botulinum toxin A to the upper esophageal sphincter for oropha-ryngeal dysphagia in two patients with inclusion body myositis.Can. J. Gastroenterol. 18(6), 397–399.

    PubMed  Google Scholar 

  • Lysy J, Y Israelit-Yatzkan, M Sestiery-Ittah, S Weksler-Zangen, D Keret and E Goldin (2001) Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure.Gut 48(2), 221–224.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Madalinski MH, J Slawek, B Zbytek, W Duzynski, Z Adrich, K Jagiello and A Kryszewski (2001) Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure.Hepatogastroenterology 48(40), 977–979.

    CAS  PubMed  Google Scholar 

  • Madalinski M, Z Adrich and A Kryszewski (2002) [Nitric oxide donors and their potentiating effects after botulinum toxin application for treatment of chronic anal fissure].Pol. Arch. Med. Wewn. 107(1), 69–74.

    PubMed  Google Scholar 

  • Maria G, E Cassetta, D Gui, G Brisinda, AR Bentivoglio and A Albanese (1998) A comparison of botulinum toxin and saline for the treatment of chronic anal fissure.N. Engl. J. Med. 338(4), 217–220.

    Article  CAS  PubMed  Google Scholar 

  • Maria G, G Brisinda, AR Bentivoglio, E Cassetta, D Gui and A Albanese (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure.Am. J. Surg. 179(1), 46–50.

    Article  CAS  PubMed  Google Scholar 

  • Maria G, G Brisinda, AR Bentivoglio, A Albanese, G Sganga and Castagneto M (2001) Anterior rectocele due to obstructed defecation relieved by botulinum toxin.Surgery 129(5), 524–529.

    Article  CAS  PubMed  Google Scholar 

  • Massoud BW, V Mehrdad, T Baharak and Z Alireza (2005) Botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure. Ann.Saudi Med. 25(2), 140–142.

    Google Scholar 

  • Mentes BB, O Irkorucu, M Akin, S Leventoglu and E Tatlicioglu (2003) Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.Dis. Colon Rectum 46(2), 232–237.

    Article  PubMed  Google Scholar 

  • Mikaeli J, A Fazel, G Montazeri, M Yaghoobi and R Malekzadeh (2001) Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia.Aliment. Pharmacol. Ther. 15(9), 1389–1396.

    Article  CAS  PubMed  Google Scholar 

  • Miller LS, SV Pullela, HP Parkman, TD Schiano, MJ Cassidy, S Cohen and RS Fisher (2002a) Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastro-esophageal junction.Am. J. Gastroenterol. 97(7), 1640–1646.

    Article  PubMed  Google Scholar 

  • Miller LS, GA Szych, SB Kantor, MQ Bromer, LC Knight, AH Maurer, RS Fisher and HP Parkman (2002b) Treatment of idio-pathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.Am. J. Gastroenterol. 97, 1653–1660.

    Article  CAS  PubMed  Google Scholar 

  • Moerman M, Y Callier, C Dick and H Vermeersch (2002) Botulinum toxin for dysphagia due to cricopharyngeal dysfunction.Eur. Arch. Otorhinolaryngol. 259(1), 1–3.

    Article  PubMed  Google Scholar 

  • Muehldorfer SM, EG Hahn and C Ell (1997) Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis.Endoscopy 29(2), 120–124.

    Article  CAS  PubMed  Google Scholar 

  • Muehldorfer SM, TH Schneider, J Hochberger, P Martus, EG Hahn and Ell C (1999) Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation.Endoscopy 31(7), 517–521.

    Article  CAS  PubMed  Google Scholar 

  • Murry T, T Wasserman, RL Carrau and B Castillo (2005) Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter.Am. J. Otolaryngol. 26(3), 157–162.

    Article  CAS  PubMed  Google Scholar 

  • Neubrand M, C Scheurlen, M Schepke and T Sauerbruch (2002) Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.Endoscopy 34(7), 519–523.

    Article  CAS  PubMed  Google Scholar 

  • Olgart C, LE Gustafsson and NP Wiklund (2000) Evidence for nonvesicular nitric oxide release evoked by nerve activation.Eur. J. Neurosci. 12(4), 1303–1309.

    Article  CAS  PubMed  Google Scholar 

  • Parameswaran MS and AM Soliman (2002) Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Ann.Otol. Rhinol. Laryngol. 111(10), 871–874.

    Article  Google Scholar 

  • Pasricha PJ, WJ Ravich and AN Kalloo (1993) Botulinum toxin for achalasia.Lancet 341(8839), 244–245.

    Article  CAS  PubMed  Google Scholar 

  • Pasricha PJ, EP Miskovsky and AN Kalloo (1994a) Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction.Gut 35(9), 1319–1321.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pasricha PJ, WJ Ravich, TR Hendrix, S Sostre, BS Jones and AN Kalloo N (1994b) Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann.Intern. Med. 121(8), 590–591.

    CAS  Google Scholar 

  • Pasricha PJ, WJ Ravich, TR Hendrix, S Sostre, B Jones and AN Kalloo, A. N (1995) Intrasphincteric botulinum toxin for the treatment of achalasia.N. Engl. J. Med. 332(12), 774–778.

    Article  CAS  PubMed  Google Scholar 

  • Pasricha PJ, R Rai, WJ Ravich, TR Hendrix and AN Kalloo (1996) Botulinum toxin for achalasia: long-term outcome and predictors of response.Gastroenterology 110(5), 1410–1415.

    Article  CAS  PubMed  Google Scholar 

  • Ravich WJ (2001) Botulinum toxin for UES dysfunction: therapy or poison?Dysphagia 16(3), 168–170.

    Article  CAS  PubMed  Google Scholar 

  • Restivo DA, A Palmeri and R Marchese-Ragona (2002) Botulinum toxin for cricopharyngeal dysfunction in Parkinson’s disease.N. Engl. J. Med. 346(15), 1174–1175.

    Article  PubMed  Google Scholar 

  • Reynolds JC and HP Parkman (1989) Achalasia.Gastroenterol. Clin. North Am. 18(2), 223–255.

    CAS  PubMed  Google Scholar 

  • Rollnik JD, PN Meier, MP Manns and M Goke (2003) Antral injections of botulinum a toxin for the treatment of obesity.Ann. Intern. Med. 138(4), 359–360.

    Article  PubMed  Google Scholar 

  • Ron Y, Y Avni, A Lukovetski, J Wardi, D Geva, S Birkenfeld and Z Halpern (2001) Botulinum toxin type-A in therapy of patients with anismus.Dis. Colon Rectum 44(12), 1821–1826.

    Article  CAS  PubMed  Google Scholar 

  • Schneider I, WF Thumfart, C Pototschnig and HE Eckel (1994) Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method.Ann. Otol. Rhinol. Laryngol. 103(1), 31–35.

    Article  CAS  PubMed  Google Scholar 

  • Schouten WR, JW Briel, JJ Auwerda and MO Boerma (1996) Anal fissure: new concepts in pathogenesis and treatment.Scand. J. Gastroenterol. Suppl.218, 78–81.

    Article  CAS  PubMed  Google Scholar 

  • Shafik A and O El-Sibai (1998) Botulinum toxin in the treatment of nonrelaxing puborectalis syndrome.Dig. Surg. 15(4), 347–351.

    Article  CAS  PubMed  Google Scholar 

  • Shaw GY and JP Searl (2001) Botulinum toxin treatment for cricopharyngeal dysfunction.Dysphagia 16(3), 161–167.

    Article  CAS  PubMed  Google Scholar 

  • Siproudhis L, V Sebille, F Pigot, P Hemery, F Juguet and E Bellissant (2003) Lack of effficacy of botulinum toxin in chronic anal fissure.Aliment. Pharmacol. Ther. 18(5), 515–524.

    Article  CAS  PubMed  Google Scholar 

  • Storr M, HD Allescher, T Rosch, P Born, N Weigert and M Classen (2001) Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up.Gastrointest. Endosc. 54(6), 754–759.

    Article  CAS  PubMed  Google Scholar 

  • Storr M, R Linke, M Nicolaus, B Goke and J Schirra (2005) [Injection of botulinum toxin for diffuse esophageal spasm].Dtsch. Med. Wochenschr. 130(6), 266–269.

    Article  CAS  PubMed  Google Scholar 

  • Thornton MJ, ML Kennedy and DW King (2005) Prospective manometric assessment of botulinum toxin and its correlation with healing of chronic anal fissure.Dis. Colon Rectum 48(7), 1424–1431.

    Article  CAS  PubMed  Google Scholar 

  • Vaezi MF, JE Richter, CM Wilcox, PL Schroeder, S Birgisson, RL Slaughter, RE Koehler and ME Baker (1999) Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.Gut 44(2), 231–239.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vogel JD (1999) A comparison of botulinum toxin and nitroglyc-erin ointment for chronic anal fissure.N. Engl. J. Med. 341(22), 1701.

    CAS  PubMed  Google Scholar 

  • Watanabe C, T Katakura, H Seino, Y Ota and S Kinai (1975) [A method of multidle body-section repersentation using x-ray television. Study on fluoroscopic tomography. I. (author’s transl)].Nippon Igaku Hoshasen Gakkai Zasshi 35(6), 383–393.

    CAS  PubMed  Google Scholar 

  • Wehrmann T, H Seifert, M Seipp, B Lembcke and WF Caspary (1998) Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.Endoscopy 30(8), 702–707.

    Article  CAS  PubMed  Google Scholar 

  • Wehrmann T, T Schmitt and H Seifert (1999) Endoscopic botulinum toxin injection into the minor papilla for treatment of idio-pathic recurrent pancreatitis in patients with pancreas divisum.Gastrointest. Endosc. 50(4), 545–548.

    Article  CAS  PubMed  Google Scholar 

  • Wehrmann T, TH Schmitt, A Arndt, B Lembcke, WF Caspary and Seifert, H (2000) Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction.Aliment. Pharmacol. Ther. 14(11), 1469–1477.

    Article  CAS  PubMed  Google Scholar 

  • Yokoyama T, M Asai, M Kumada, S Usui and T Kobayasi (2003) [Botulinum toxin injection into the cricopharyngeal muscle for dysphagia: report of 2 successful cases].Nippon Jibiinkoka Gakkai Kaiho 106(7), 754–757.

    Article  PubMed  Google Scholar 

  • Zaninotto G, V Annese, M Costantini, A Del Genio, M Costantino, M Epifani, G Gatto, V D’Onofrio, L Benini, S Contini, D Molena, G Battaglia, B Tardio, A Andriulli and E Ancona (2004a) Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.Ann. Surg. 239(3), 364–370.

    Article  PubMed Central  PubMed  Google Scholar 

  • Zaninotto G, R Marchese Ragona, C Briani, M Costantini, C Rizzetto, G Portale, L Zanetti, S Masiero, M Costantino, L Nicoletti, A Polidoro, G Feltrin, C Angelini, E Ancona, D Guidolin and AR Parenti (2004b) The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia.J. Gastrointest. Surg. 8(8), 997–1006.

    Article  PubMed  Google Scholar 

  • Zaninotto G, V Vergadoro, V Annese, M Costantini, M Costantino, D Molena, C Rizzetto, M Epifani, A Ruol, L Nicoletti and E Ancona (2004c) Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial.Surg. Endosc. 18(4), 691–695.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pankaj Jay Pasricha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vittal, H., Pasricha, P.J. Botulinum toxin for gastrointestinal disorders: Therapy and mechanisms. neurotox res 9, 149–159 (2006). https://doi.org/10.1007/BF03033934

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033934

Keywords

Navigation